Tests Starting with the Letters O/Ö
Laboratory Test Guide: Tests Starting with the Letters "O and Ö"
Below is the complete list of all tests starting with the letters "O and Ö" that are performed in the Medical Laboratories of Egemed Hospitals. So that our patients can have preliminary information about the tests, a short medical description and the laboratory purpose of each analysis group are clearly stated.
Biochemistry and Metabolism Tests
OXALATE 24-Hour Urine
Description: This is the measurement of how much oxalate, one of the most fundamental causes of kidney stone formation in the body, is excreted by the kidneys over 24 hours.
Purpose: It is requested to calculate the risk of recurrent kidney stones and to diagnose rare inherited metabolic diseases such as primary hyperoxaluria.
OXALATE (Serum)
Description: This is the sensitive analysis of the amount of free oxalate molecules in the bloodstream (serum) that cannot be excreted in the urine.
Purpose: It is used to detect and monitor the deposition of oxalate in other organs (systemic oxalosis) in patients with severe kidney failure.
OXALATE Spot Urine
Description: This is a rapid oxalate measurement performed on a single (spot) urine sample given at any time of the day, based on the ratio to creatinine.
Purpose: It is used to perform a rapid preliminary screening of kidney stone risk, especially in infants and children, when 24-hour urine collection is difficult.
OSMOLALITY, Urine
Description: This is a highly specific measurement showing the total concentration of all particles dissolved in the urine (sodium, potassium, urea, etc.).
Purpose: It is used to evaluate the kidneys' capacity to concentrate or dilute urine and to determine the rate of the body's fluid loss.
OSMOLALITY, Serum
Description: This is the sensitive analysis of the body's water balance and electrolyte level by calculating the total particle concentration in the blood.
Purpose: It plays a vital role in diagnosing severe water loss (dehydration), water intoxication, and antidiuretic hormone disorders such as "diabetes insipidus" (Diabetes Insipidus).
Immunology and Neurology (Neuroimmunology) Panels
OLIGOCLONAL BAND ANALYSIS (IEF)
Description: This is the search for specific antibody bands (IgG) produced by the immune system, by matching cerebrospinal fluid (CSF) with blood collected at the same time using the Isoelectric Focusing (IEF) method.
Purpose: It is the gold standard test used to make a definitive diagnosis of multiple sclerosis (MS) and chronic inflammatory conditions of the central nervous system (encephalitis).
AUTOIMMUNE LIVER ANTIBODY PROFILE
Description: This is the screening, as a broad panel, of a series of autoantibodies that arise when the immune system goes out of control and attacks a person's own liver cells and bile ducts.
Purpose: It is used to make a definitive distinction between non-viral (not Hepatitis B/C, etc.) diseases in which the body destroys itself, namely "autoimmune hepatitis" and "primary biliary cholangitis".
AUTOIMMUNE LIMBIC ENCEPHALITIS PANEL
Description: This is an advanced, specific test that detects in the blood the presence of antibodies causing neurological destruction that target the cells of the "limbic" region of the brain, which governs memory, emotion, and behavior.
Purpose: It is used to diagnose autoimmune encephalitis, a disease that presents with unexplained persistent seizures (epilepsy), sudden memory loss, and severe psychiatric findings.
AUTOIMMUNE LIMBIC ENCEPHALITIS PANEL, CSF
Description: This is the examination of autoantibodies that attack the brain, taken directly from the target area, that is, from the cerebrospinal fluid (CSF).
Purpose: It is used to clearly confirm autoimmune or cancer-related (paraneoplastic) brain inflammation that is actively continuing inside the nervous system, even if the blood result is negative.
Hematology and Genetic (DNA) Analyses
OSMOTIC FRAGILITY (With Incubation)
Description: This is the laboratory testing of how easily red blood cells (erythrocytes) break down (their resistance to hemolysis) after being incubated for 24 hours in fluids with reduced salt concentration.
Purpose: It is performed to diagnose blood cell destruction caused by congenital shape abnormalities of the cell membrane, especially "hereditary spherocytosis".
OSTEOGENESIS IMPERFECTA (COL1A1)
Description: This is the search, at the molecular level, for inherited DNA mutations in the "COL1A1" gene, which disrupt the production of Type 1 collagen protein that gives bones their strength.
Purpose: It is used to make a definitive genetic diagnosis of osteogenesis imperfecta, commonly known as "brittle bone disease", which presents with frequent bone fractures, and to determine risks within the family.